| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | BRD1812 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.0046 | 0.9 |
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | temsirolimus | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |